The new NanoKnife is a game-changer for treating Prostate cancer
WalesOnline - 03-Jan-2022Electric current damages the cell membranes of the cancerous cells
Join the club for FREE to access the whole archive and other member benefits.
Professor of Surgery at University College London
Holds the positions of Professor of Interventional Oncology at UCL and Honorary Consultant Urologist at UCLH.
In April 2012, he was appointed Director to the Division of Surgery and Interventional Science. During this time, he has re-structured the Division into 3 broad research themes: Materials and Tissue; Tissue and Energy; and Nanotechnology. Each research theme look very much to the surgery of the future: where implants will interact or be replaced by the patient's own tissue; where beams of energy will replace surgeons' knives; and where organs will be engineered to order.
He leads an internationally recognised research group that looks to more accurate ways of diagnosing men with prostate cancer and treatments that are better tolerated and cause less harm. He is a major grant holder, a frequent speaker at international meetings and has published over 250 peer reviewed scientific papers.
Visit website: https://www.uclh.nhs.uk/our-services/find-consultant/professor-mark-emberton
See also: University College London (UCL) - Diverse global community of world-class academics, students, industry links, external partners, and alumni
Details last updated 04-Jan-2022
Electric current damages the cell membranes of the cancerous cells